Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: A side study of the SPCG-7 randomized trial

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 1, 2011, Pages 55-61

  Solberg, Arne ^a   Haugen, Olav A ^a,b   Viset, Trond ^a   Bergh, Anders ^d   Tasdemir, Ilker ^c   Ahlgren, Göran ^e   Widmark, Anders ^d   Angelsen, Anders ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endocrine therapy; Outcome; Posttreatment biopsy; Prostate cancer; Radiotherapy

Indexed keywords

COMBINED TREATMENT; ENDOCRINE THERAPY; GLEASON SCORES; HAZARD RATIO; LOCAL TUMOR CONTROL; MULTIVARIABLE ANALYSIS; ODDS RATIOS; OUTCOME; POST TREATMENT; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; RADICAL RADIOTHERAPY; RANDOMIZED TRIAL; RESIDUAL TUMORS; TUMOR PROGRESSIONS;

ANTIGENS; BIOPSY; PATIENT MONITORING; PESTICIDE EFFECTS; RADIOTHERAPY; TUMORS;

DISEASES;

ANTIANDROGEN; BICALUTAMIDE; FLUTAMIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; DISEASE COURSE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SCANDINAVIA; TREATMENT OUTCOME;

AGED; ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FLUTAMIDE; FOLLOW-UP STUDIES; HUMANS; LEUPROLIDE; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NITRILES; ODDS RATIO; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TOSYL COMPOUNDS;

EID: 79954419739     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.072     Document Type: Article

References (34)

1. P. Iversen, C.J. Tyrrell, and A.V. Kaisary Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup J Urol 164 2000 1579 1582
2. M. Bolla, D. Gonzalez, and P. Warde Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 1997 295 300 (Pubitemid 27318990)
3. A.V. D'Amico, J. Manola, and M. Loffredo 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial JAMA 292 2004 821 827 (Pubitemid 39079668)
4. D.G. McLeod, P. Iversen, and W.A. See Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer BJU Int 97 2006 247 254
5. M. Bolla, T.M. de Reijke, and G. Van Tienhoven Duration of androgen suppression in the treatment of prostate cancer N Engl J Med 360 2009 2516 2527
6. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996 (Pubitemid 46622106)
7. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239 (Pubitemid 41352111)
8. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74 (Pubitemid 350251041)
9. A. Widmark, O. Klepp, and A. Solberg Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial Lancet 373 2009 301 308
10. C.J. Rosser, D.A. Kuban, and L.B. Levy Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer J Urol 168 2002 2001 2005
11. M. Roach 3rd, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
12. W. Vance, S.L. Tucker, and R. de Crevoisier The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome Int J Radiat Oncol Biol Phys 67 2007 828 833 (Pubitemid 46215871)
13. J. Crook, S. Malone, and G. Perry Postradiotherapy prostate biopsies: What do they really mean? Results for 498 patients Int J Radiat Oncol Biol Phys 48 2000 355 367
14. J.J. Coen, A.L. Zietman, and H. Thakral Radical radiation for localized prostate cancer: Local persistence of disease results in a late wave of metastases J Clin Oncol 20 2002 3199 3205 (Pubitemid 34831515)
15. M.J. Zelefsky, V.E. Reuter, and Z. Fuks Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer J Urol 179 2008 1368 1373 discussion 1373
16. S. Levegrun, A. Jackson, and M.J. Zelefsky Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer Radiother Oncol 63 2002 11 26 (Pubitemid 34626750)
17. J. Laverdiere, J.L. Gomez, and L. Cusan Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer Int J Radiat Oncol Biol Phys 37 1997 247 252 (Pubitemid 27138705)
18. M.K. Brawer, R.B. Nagle, and W. Pitts Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates Cancer 63 1989 454 460 (Pubitemid 19038459)
19. J.I. Epstein, W.C. Allsbrook Jr., and M.B. Amin The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 2005 1228 1242 (Pubitemid 41232997)
20. E. Vittinghoff, and C.E. McCulloch Relaxing the rule of ten events per variable in logistic and Cox regression Am J Epidemiol 165 2007 710 718 (Pubitemid 46348374)
21. J.D. Cox, and T.J. Stoffel The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate Cancer 40 1977 156 160 (Pubitemid 8160517)
22. G. Ljung, M. Norberg, and H. Hansson Transrectal ultrasonically-guided core biopsies in the assessment of local cure of prostatic cancer after radical external beam radiotherapy Acta Oncol 34 1995 945 952
23. T. Granfors, J.E. Damber, and A. Bergh Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma Int J Radiat Oncol Biol Phys 39 1997 1031 1036 (Pubitemid 27506154)
24. J. Crook, S. Robertson, and G. Collin Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate Int J Radiat Oncol Biol Phys 27 1993 31 37 (Pubitemid 23270654)
25. A. Berner, S. Harvei, and S. Tretli Prostatic carcinoma: A multivariate analysis of prognostic factors Br J Cancer 69 1994 924 930 (Pubitemid 24140677)
26. M.K. Buyyounouski, A.L. Hanlon, and E.M. Horwitz Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy Int J Radiat Oncol Biol Phys 70 2008 59 66 (Pubitemid 350251025)
27. F.J. Murat, L. Poissonnier, and M. Rabilloud Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer Eur Urol 55 2009 640 647
28. F.J. Bianco Jr., P.T. Scardino, and A.J. Stephenson Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy Int J Radiat Oncol Biol Phys 62 2005 448 453 (Pubitemid 40704461)
29. D.K. Bahn, F. Lee, and P. Silverman Salvage cryosurgery for recurrent prostate cancer after radiation therapy: A seven-year follow-up Clin Prostate Cancer 2 2003 111 114 (Pubitemid 37296105)
30. T. Granfors, R. Tomic, and A. Bergh After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour Urol Res 27 1999 357 361 (Pubitemid 29526141)
31. D. Pomerantz, and N. Vogelzang Monitoring response, prediction methodology, staging, and imaging in prostate cancer Rev Urol 8 Suppl 2 2006 S30 S34
32. J. Walz, M. Graefen, and F.K. Chun High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series Eur Urol 50 2006 498 505 (Pubitemid 44189057)
33. B. Djavan, V. Ravery, and A. Zlotta Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop? J Urol 166 2001 1679 1683
34. G.E. Hanks, A.L. Hanlon, and B. Epstein Dose response in prostate cancer with 8-12 years' follow-up Int J Radiat Oncol Biol Phys 54 2002 427 435 (Pubitemid 35286808)